RTM added as distributor NeuraCeq®

Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F) will soon be available from Radboud Translational Medicine (RTM) in Nijmegen, The Netherlands. We're delighted to announce that the European Medicine Agency has approved the Type IB variation to the NeuraCeq EU dossier, adding RTM to the distribution network.

For more information on NeuraCeq®, including safety information, please visit: https://neuraceq.com/

Other news

GMP-certificate received

Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...

1st production QuiremSpheres

On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...

Upcoming event

From October 15 to October 19, Radboud translational medicine will attend the 29th annual congress o...

LinkedIn post ESRR2024

📢 Important update on EU #GMP Annex 1 at #ESRR2024!  The revised EU GMP Annex 1, effecti...

News